Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041752 | SCV000065448 | pathogenic | Rare genetic deafness | 2012-03-06 | criteria provided, single submitter | clinical testing | The Trp4727X variant in USH2A has not been reported in the literature nor previo usly identified by our laboratory. This nonsense variant leads to a premature te rmination codon at position 4727, which is predicted to lead to a truncated or a bsent protein. In summary, this variant meets our criteria to be classified as p athogenic (http://pcpgm.partners.org/LMM). |
Counsyl | RCV000674521 | SCV000799870 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001380766 | SCV001578924 | pathogenic | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp4727*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 25649381, 29912909). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 48429). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003450783 | SCV004183096 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450782 | SCV004183097 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003450783 | SCV005055686 | pathogenic | Retinitis pigmentosa 39 | 2024-03-18 | criteria provided, single submitter | clinical testing |